Pacific Biosciences Of California, Inc.

RHUMBLINE ADVISERS PACB

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

360,963

Value ($000)

675

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	675	0.0%	360,963	12/31/2025
2025 Q3	11/6/2025	532	0.0%	415,679	9/30/2025
2025 Q2	8/12/2025	505	0.0%	407,147	6/30/2025
2025 Q1	5/29/2025	518	0.0%	438,775	3/31/2025
2024 Q4	5/29/2025	766	0.0%	418,622	12/31/2024
2024 Q3	11/12/2024	702	0.0%	412,900	9/30/2024
2024 Q2	8/1/2024	598	0.0%	436,868	6/30/2024
2024 Q1	5/9/2024	1,444	0.0%	385,141	3/31/2024
2023 Q4	2/8/2024	3,760	0.0%	383,318	12/31/2023
2023 Q3	11/9/2023	3,198	0.0%	382,984	9/30/2023
2023 Q2	8/8/2023	5,075	0.0%	381,591	6/30/2023
2023 Q1	5/11/2023	4,673	0.0%	403,505	3/31/2023
2022 Q4	2/14/2023	2,937	0.0%	359,045	12/31/2022
2022 Q3	11/10/2022	2,048	0.0%	352,808	9/30/2022
2022 Q2	8/11/2022	1,456	0.0%	329,479	6/30/2022
2022 Q1	5/12/2022	2,155	0.0%	236,802	3/31/2022
2021 Q4	2/10/2022	5,014	0.0%	245,074	12/31/2021
2021 Q3	11/12/2021	6,342	0.0%	248,203	9/30/2021
2021 Q2	8/5/2021	8,734	0.0%	249,771	6/30/2021
2021 Q1	5/6/2021	7,176	0.0%	215,441	3/31/2021
2020 Q4	2/10/2021	5,810	0.0%	223,987	12/31/2020
2020 Q3	11/12/2020	1,938	0.0%	196,399	9/30/2020
2020 Q2	8/13/2020	730	0.0%	211,482	6/30/2020
2020 Q1	5/6/2020	595	0.0%	194,361	3/31/2020
2019 Q4	2/5/2020	1,036	0.0%	201,480	12/31/2019
2014 Q2	8/6/2014	345	0.0%	55,821	6/30/2014
2014 Q1	5/6/2014	366	0.0%	68,494	3/31/2014
2013 Q4	2/3/2014	361	0.0%	69,114	12/31/2013